New Drugs FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients 5 years ago
New Drug Applications Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV 5 years ago
New Drug Applications U.S. FDA Accepts New Drug Application and Grants Priority Review for Darolutamide 5 years ago
New Drug Applications Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain 5 years ago
New Drug Applications Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review 5 years ago
Pharma Industry News Winners announced for the 2019 Clinical Researcher of the Year – The Americas competition! 5 years ago